Author Index
Search or browse for an author across our entire electronic archive
Search results for: D
Results 921 - 930 of 1338 shown below
Donnini, S
L Morbidelli, S Donnini, S Filippi, L Messori, F Piccioli, P Orioli, G Sava and M Ziche
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
doi:10.1038/sj.bjc.6600906
Abstract | Full article | PDF
Dono, K
H Ota, H Nagano, M Sakon, H Eguchi, M Kondo, T Yamamoto, M Nakamura, B Damdinsuren, H Wada, S Marubashi, A Miyamoto, K Dono, K Umeshita, S Nakamori, K Wakasa and M Monden
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-
and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expressionadvance online publication, 2005-08-16 00:00:00.000;
doi:10.1038/sj.bjc.6602742
Abstract | Full article | PDF
-
T Noda, H Nagano, I Takemasa, S Yoshioka, M Murakami, H Wada, S Kobayashi, S Marubashi, Y Takeda, K Dono, K Umeshita, N Matsuura, K Matsubara, Y Doki, M Mori and M Monden
Activation of Wnt/
-catenin signalling pathway induces chemoresistance to interferon-
/5-fluorouracil combination therapy for hepatocellular carcinomaadvance online publication, 2009-04-28 00:00:00.000;
doi:10.1038/sj.bjc.6605064
Abstract | Full article | PDF
-
Y Ito, N Matsuura, M Sakon, T Takeda, K Umeshita, H Nagano, S Nakamori, K Dono, M Tsujimoto, M Nakahara, K Nakao and M Monden
Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma
doi:10.1038/sj.bjc.6690758
-
Y Ito, M Monden, T Takeda, H Eguchi, K Umeshita, H Nagano, S Nakamori, K Dono, M Sakon, M Nakamura, M Tsujimoto, M Nakahara, K Nakao, Y Yokosaki and N Matsuura
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
doi:10.1054/bjoc.1999.1065
Dono, M
G Cutrona, P Tasso, M Dono, S Roncella, M Ulivi, E M Carpaneto, V Fontana, M Comis, F Morabito, M Spinelli, E Frascella, L C Boffa, G Basso, V Pistoia and M Ferrarini
CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL
doi:10.1038/sj.bjc.6600329
Abstract | Full article | PDF
Donovan, J
Z Kote-Jarai, S Jugurnauth, S Mulholland, D A Leongamornlert, M Guy, S Edwards, M Tymrakiewitcz, L O'Brien, A Hall, R Wilkinson, A A Al Olama, J Morrison, K Muir, D Neal, J Donovan, F Hamdy, D F Easton and R Eeles
A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
advance online publication, 2009-01-06 00:00:00.000;
doi:10.1038/sj.bjc.6604847
Abstract | Full article | PDF
-
N Pashayan, S W Duffy, P Pharoah, D Greenberg, J Donovan, R M Martin, F Hamdy and D E Neal
Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening
advance online publication, 2009-03-17 00:00:00.000;
doi:10.1038/sj.bjc.6604973
Abstract | Full article | PDF
Donovan, J L
D Gunnell, S E Oliver, T J Peters, J L Donovan, R Persad, M Maynard, D Gillatt, A Pearce, F C Hamdy, D E Neal and J M P Holly
Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men
doi:10.1038/sj.bjc.6600946
Abstract | Full article | PDF
-
C Metcalfe, J A Lane, F Hamdy, D Neal and J L Donovan
A model of the natural history of screen-detected prostate cancer
advance online publication, 2006-09-26 00:00:00.000;
doi:10.1038/sj.bjc.6603368
Abstract | Full article | PDF
Donovan, M
M J Smith, A C Culhane, M Donovan, J C Coffey, B D Barry, M A Kelly, D G Higgins, J H Wang, W O Kirwan, T G Cotter and H P Redmond
Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification
doi:10.1038/sj.bjc.6604931
Abstract | Full article | PDF
Donskov, F
F Donskov, K M Bennedsgaard, H von der Maase, N Marcussen, R Fisker, J J Jensen, P Naredi and M Hokland
Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival
doi:10.1038/sj.bjc.6600437
Abstract | Full article | PDF
-
F Donskov, N Marcussen, M Hokland, R Fisker, H H T Madsen and H von der Maase
In vivo assessment of the antiproliferative properties of interferon-alpha during immunotherapy: Ki-67 (MIB-1) in patients with metastatic renal cell carcinoma
doi:10.1038/sj.bjc.6601587
Abstract | Full article | PDF
-
F Donskov, M Middleton, K Fode, P Meldgaard, W Mansoor, J Lawrance, N Thatcher, H Nellemann and H von der Maase
Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma
advance online publication, 2005-08-30 00:00:00.000;
doi:10.1038/sj.bjc.6602768
Abstract | Full article | PDF
-
F Donskov, M Hokland, N Marcussen, H H Torp Madsen and H von der Maase
Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma – results from a randomised phase II trial
doi:10.1038/sj.bjc.6602937
Abstract | Full article | PDF
Doody, M M
K J Johnson, B H Alexander, M M Doody, A J Sigurdson, M S Linet, L G Spector, R W Hoffbeck, S L Simon, R M Weinstock and J A Ross
Childhood cancer in the offspring born in 1921–1984 to US radiologic technologists
advance online publication, 2008-07-29 00:00:00.000;
doi:10.1038/sj.bjc.6604516
Abstract | Full article | PDF
Doolan, P
S Kennedy, M Clynes, P Doolan, J P Mehta, S Rani, J Crown and L O'Driscoll
SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue
advance online publication, 2008-05-13 00:00:00.000;
doi:10.1038/sj.bjc.6604365
Abstract | Full article | PDF
Dooley, M J
M J Dooley, S Singh and D Rischin
Rounding of low serum creatinine levels and consequent impact on accuracy of bedside estimates of renal function in cancer patients
doi:10.1038/sj.bjc.6601641
Abstract | Full article | PDF
-
L J Worth, M J Dooley, J F Seymour, L Mileshkin, M A Slavin and K A Thursky
An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital
advance online publication, 2005-02-22 00:00:00.000;
doi:10.1038/sj.bjc.6602412
Abstract | Full article | PDF
-
Result page:
- 1|
- 2|
- 3|
- 4|
- 5|
- 6|
- 7|
- 8|
- 9|
- 10|
- 11|
- 12|
- 13|
- 14|
- 15|
- 16|
- 17|
- 18|
- 19|
- 20|
- 21|
- 22|
- 23|
- 24|
- 25|
- 26|
- 27|
- 28|
- 29|
- 30|
- 31|
- 32|
- 33|
- 34|
- 35|
- 36|
- 37|
- 38|
- 39|
- 40|
- 41|
- 42|
- 43|
- 44|
- 45|
- 46|
- 47|
- 48|
- 49|
- 50|
- 51|
- 52|
- 53|
- 54|
- 55|
- 56|
- 57|
- 58|
- 59|
- 60|
- 61|
- 62|
- 63|
- 64|
- 65|
- 66|
- 67|
- 68|
- 69|
- 70|
- 71|
- 72|
- 73|
- 74|
- 75|
- 76|
- 77|
- 78|
- 79|
- 80|
- 81|
- 82|
- 83|
- 84|
- 85|
- 86|
- 87|
- 88|
- 89|
- 90|
- 91|
- 92|
- 93|
- 94|
- 95|
- 96|
- 97|
- 98|
- 99|
- 100|
- 101|
- 102|
- 103|
- 104|
- 105|
- 106|
- 107|
- 108|
- 109|
- 110|
- 111|
- 112|
- 113|
- 114|
- 115|
- 116|
- 117|
- 118|
- 119|
- 120|
- 121|
- 122|
- 123|
- 124|
- 125|
- 126|
- 127|
- 128|
- 129|
- 130|
- 131|
- 132|
- 133|
- 134|
- Next
